GE Healthcare's biopharmaceutical factory KUBio is the first modular facility to manufacture monoclonal antibodies. The 1,200 m2 facility uses GE Healthcare's Ready-to-Process single-use technologies and the company claims total planning, delivery and construction can be achieved in 14–18 months.